# FDA recall Z-0780-2024

> **Medtronic Neuromodulation** · Class II · device recall initiated 2023-12-19.

## Product

Model A710 Intellis Clinician Programmer Application, version 2.0.97

## Reason for recall

Medtronic has discovered an instance in which the Intellis A710 Clinician Programmer Application (CP App) could no longer establish a session with the Implantable Neurostimulator (INS) which resulted in the inability for the clinician to adjust stimulation parameters. In the event of this issue, the patient may receive inadequate or excessive therapy and experience non-optimal pain relief.

## Distribution

Germany

## Key facts

- **Recall number:** Z-0780-2024
- **Recalling firm:** Medtronic Neuromodulation
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2023-12-19
- **Report date:** 2024-01-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Minneapolis, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0780-2024

## Citation

> AI Analytics. FDA recall Z-0780-2024. Retrieved 2026-07-19 from https://api.ai-analytics.org/recall/Z-0780-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*